NDT Advance Access originally published online on January 5, 2007
Nephrology Dialysis Transplantation 2007 22(4):1171-1176; doi:10.1093/ndt/gfl718
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mineral metabolism parameters throughout chronic kidney disease stages 1–5—achievement of K/DOQI target ranges
1Hospital Universitari Arnau de Vilanova Lleida, 2University of Lleida, and 3Hospital Galdakao. Vizcaya, Av. Rovira Roure, 25198 Lleida, Spain
Correspondence and offprint requests to: Lourdes Craver, Hospital Universitari Arnau de Vilanova, Av Rovira Roure, 25198 Lleida, Spain. Email: lcraver{at}arnau.scs.es
 |
Abstract |
|---|
Background. Dialysis Outcomes and Practice Patterns Study has shown that the proportion of haemodialysis patients with adequate mineral metabolism parameters according to the Kidney Disease Outcome Quality Initiative (K/DOQI) guidelines is very low. The adequacy of such parameters in relation to the recommended ranges in patients with different chronic kidney disease (CKD) stages has not been reported. The objective of this study is to provide an in-depth description of mineral metabolism in the early stages of CKD in a European population, and to compare it with current recommendations for stages 3–5 (K/DOQI guidelines).
Methods. A total of 1836 patients were classified into stages 1–5 according to K/DOQI guidelines. The following clinical and biochemical data were recorded: age, gender, CKD aetiology, presence of diabetes, serum creatinine, creatinine clearance, serum phosphate, calcium, Ca x P product and intact parathyroid hormone (PTH).
Results. A decrease in 1,25-dihydroxyvitamin D and an increase in PTH are the earliest mineral metabolism alterations in CKD, while serum calcium and phosphate are altered later in the course of CKD. The percentages of patients with serum levels within the recommended K/DOQI guidelines for stages 3, 4 and 5 were as follows: serum calcium: 90.7, 85.6 and 55; serum phosphate: 90.9, 77.1 and 70.3; iPTH 42.4, 24.6 and 46.8 and Ca x P product 99.9, 99.6 and 83.8, respectively. The percentages of patients who had all four parameters within the recommended ranges were 34.9, 18.4 and 21.6 for stages 3, 4 and 5, respectively.
Conclusion. Mineral metabolism disturbances start early in the course of CKD. The first alterations to take place are a 1,25-dihydroxyvitamin D decrease, a 24 h urine phosphate decrease and a PTH elevation, which show significant level variation when the glomerular filtration rate falls below 60 ml/min. K/DOQI recommended levels for mineral metabolism parameters are difficult to accomplish, in particular for PTH levels.
Keywords: adequacy; calcium; chronic renal disease; guidelines; hyperparathyroidism; mineral metabolism; parathyroid; phosphate
*José Manuel Valdivielso and Elvira Fernández are senior co-authors.
Received for publication: 8. 7.06
Accepted in revised form: 6.11.06
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. L. Carter, S. E. O'Riordan, G. L. Eaglestone, M. P. Delaney, and E. J. Lamb Bone mineral metabolism and its relationship to kidney disease in a residential care home population: a cross-sectional study Nephrol. Dial. Transplant., June 10, 2008; (2008) gfn302v1. [Abstract] [Full Text] [PDF]
|
|